118
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE Cellular and Molecular Biology

Paradoxical Expression of Anti-Apoptotic and MRP Genes on Cancer Stem-Like Cell Isolated from TJ905 Glioblastoma Multiforme Cell Line

, , , , , , , , & show all
Pages 338-343 | Published online: 11 Jun 2009

REFERENCES

  • Levin V. A. Are gliomas preventable?. Recent Results Cancer Res 2007; 174: 205–215
  • Stupp R., Mason W. P., van den Bent M. J., Weller M., Fisher B., Taphoorn M. J., Belanger K., Brandes A. A., Marosi C., Bogdahn U., Curschmann J., Janzer R. C., Ludwin S. K., Gorlia T., Allgeier A., Lacombe D., Cairncross J. G., Eisenhauer E., Mirimanoff R. O. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352(10)987–996
  • Nakada M., Nakada S., Demuth T., Tran N. L., Hoelzinger D. B., Berens M. E. Molecular targets of glioma invasion. Cell Mol Life Sci 2007; 64(4)458–478
  • Salmaggi A., Boiardi A., Gelati M., Russo A., Calatozzolo C., Ciusani E., Sciacca F. L., Ottolina A., Parati E. A., La Porta C., Alessandri G., Marras C., Croci D., De Rossi M. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia. 2006; 54(8)850–860
  • Ghods A. J., Irvin D., Liu G., Yuan X., Abdulkadir I. R., Tunici P., Konda B., Wachsmann-Hogiu S., Black K. L., Yu J. S. Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells 2007; 25(7)1645–1653
  • Livak K. J., Schmittgen T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25(4)402–408
  • Singh S. K., Clarke I. D., Hide T., Dirks P. B. Cancer stem cells in nervous system tumors. Oncogene 2004; 23(43)7267–7273
  • Singh S. K., Hawkins C., Clarke I. D., Squire J. A., Bayani J., Hide T., Henkelman R. M., Cusimano M. D., Dirks P. B. Identification of human brain tumour initiating cells. Nature 2004; 432(7015)396–401
  • Kondo T., Setoguchi T., Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 2004; 101(3)781–786
  • Huang R. C., Chang C. C., Mold D. Survivin-dependent and -independent pathways and the induction of cancer cell death by tetra-O-methyl nordihydroguaiaretic acid. Semin Oncol 2006; 33(4)479–485
  • Fukuda S., Pelus L. M. Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 2006; 5(5)1087–1098
  • Kempkensteffen C., Hinz S., Christoph F., Krause H., Koellermann J., Magheli A., Schrader M., Schostak M., Miller K., Weikert S. Expression of the apoptosis inhibitor livin in renal cell carcinomas: correlations with pathology and outcome. Tumour Biol 2007; 28(3)132–138
  • Zaman G. J., Flens M. J., van Leusden M. R., de Haas M., Mülder H. S., Lankelma J., Pinedo H. M., Scheper R. J., Baas F., Broxterman H. J., Borst P. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 1994; 91(19)8822–8826
  • Homolya L., Varadi A., Sarkadi B. Multidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate. Biofactors 2003; 17(1–4)103–114
  • Benyahia B., Huguet S., Declèves X., Mokhtari K., Crinière E., Bernaudin J. F., Scherrmann J. M., Delattre J. Y. Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1. J Neurooncol 2004; 66(1–2)65–70
  • Haga S., Hinoshita E., Ikezaki K., Fukui M., Scheffer G. L., Uchiumi T., Kuwano M. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma. Jpn J Cancer Res 2001; 92(2)211–219

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.